Rhythm Pharmaceuticals (RYTM) Prices 5M Share Common Offering at $30/Sh

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity, today announced the pricing of its public offering of 5,000,000 shares of its common stock at a public offering price of $30.00 per share. All of the shares are being offered by Rhythm. In addition, Rhythm has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of its common stock at the public offering price, less the underwriting discount and commission. The offering is expected to close on February 9, 2021, subject to the satisfaction of customary closing conditions.

Morgan Stanley, BofA Securities, Cowen and Stifel are acting as the joint book-running managers for the offering. Canaccord Genuity is acting as lead manager for the offering.

You May Also Be Interested In

• Csquare prices IPO at $21 per share, raising $1.01 billion
• Braveheart Bio files for Nasdaq IPO under ticker BRVE
• TD Cowen Resumes Compass Diversified (CODI) at Buy